| Dr John R Lafrentz, MD | |
|
285 Chateau Dr, Huntsville, AL 35801-6401 | |
| (256) 882-0165 | |
| (256) 882-7846 |
| Full Name | Dr John R Lafrentz |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 30 Years |
| Location | 285 Chateau Dr, Huntsville, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639129885 | NPI | - | NPPES |
| 51521796 | Other | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 00023611 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Crestwood Medical Center | Huntsville, AL | Hospital |
| Huntsville Hospital | Huntsville, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Huntsville Ear,nose And Throat Physicians P.c. | 2769452606 | 3 |
News Archive
Results from a study of more than 90,000 Italian women published by the Lancet Oncology found that testing for high-risk types of the human papillomavirus (HPV) DNA is significantly more effective in preventing invasive cervical cancer than cytology (Pap testing) alone.
Investigators have discovered that some type of protective system goes into action in some cases when a baby's immune system is deficient.
The MEDICREA Group, a company that specializes in the development of personalized implants produced for a patient's specific need in the treatment of spinal pathologies, today announced the company has received 510(k) clearance from the U.S. Food and Drug Administration for UNiD, the world's first patient-specific spinal osteosynthesis rod.
Kindred Healthcare, Inc. today provided its estimate of the revenue effect of proposed rate changes to Medicare Part B therapy services included in the proposed Medicare Physician Fee Schedule rule. The proposed rule was released by the Centers for Medicare and Medicaid Services ("CMS") on June 25. The proposed rule is subject to a 60-day public comment period and is scheduled to become effective January 1, 2011.
An international team of scientists has discovered extensive similarities between a strain of bacteria commonly associated with plants and one increasingly linked to opportunistic infections in hospital patients. The findings suggest caution in the use of the plant-associated strain for a range of biotech applications. The genetic analysis was conducted in part at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory, and will be published in the July 2009 issue of Nature Reviews Microbiology, now available online.
› Verified 8 days ago
| Entity Name | Huntsville Ear,nose And Throat Physicians P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124168349 PECOS PAC ID: 2769452606 Enrollment ID: O20040728001356 |
News Archive
Results from a study of more than 90,000 Italian women published by the Lancet Oncology found that testing for high-risk types of the human papillomavirus (HPV) DNA is significantly more effective in preventing invasive cervical cancer than cytology (Pap testing) alone.
Investigators have discovered that some type of protective system goes into action in some cases when a baby's immune system is deficient.
The MEDICREA Group, a company that specializes in the development of personalized implants produced for a patient's specific need in the treatment of spinal pathologies, today announced the company has received 510(k) clearance from the U.S. Food and Drug Administration for UNiD, the world's first patient-specific spinal osteosynthesis rod.
Kindred Healthcare, Inc. today provided its estimate of the revenue effect of proposed rate changes to Medicare Part B therapy services included in the proposed Medicare Physician Fee Schedule rule. The proposed rule was released by the Centers for Medicare and Medicaid Services ("CMS") on June 25. The proposed rule is subject to a 60-day public comment period and is scheduled to become effective January 1, 2011.
An international team of scientists has discovered extensive similarities between a strain of bacteria commonly associated with plants and one increasingly linked to opportunistic infections in hospital patients. The findings suggest caution in the use of the plant-associated strain for a range of biotech applications. The genetic analysis was conducted in part at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory, and will be published in the July 2009 issue of Nature Reviews Microbiology, now available online.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John R Lafrentz, MD 285 Chateau Dr, Huntsville, AL 35801-6401 Ph: (256) 882-0165 | Dr John R Lafrentz, MD 285 Chateau Dr, Huntsville, AL 35801-6401 Ph: (256) 882-0165 |
News Archive
Results from a study of more than 90,000 Italian women published by the Lancet Oncology found that testing for high-risk types of the human papillomavirus (HPV) DNA is significantly more effective in preventing invasive cervical cancer than cytology (Pap testing) alone.
Investigators have discovered that some type of protective system goes into action in some cases when a baby's immune system is deficient.
The MEDICREA Group, a company that specializes in the development of personalized implants produced for a patient's specific need in the treatment of spinal pathologies, today announced the company has received 510(k) clearance from the U.S. Food and Drug Administration for UNiD, the world's first patient-specific spinal osteosynthesis rod.
Kindred Healthcare, Inc. today provided its estimate of the revenue effect of proposed rate changes to Medicare Part B therapy services included in the proposed Medicare Physician Fee Schedule rule. The proposed rule was released by the Centers for Medicare and Medicaid Services ("CMS") on June 25. The proposed rule is subject to a 60-day public comment period and is scheduled to become effective January 1, 2011.
An international team of scientists has discovered extensive similarities between a strain of bacteria commonly associated with plants and one increasingly linked to opportunistic infections in hospital patients. The findings suggest caution in the use of the plant-associated strain for a range of biotech applications. The genetic analysis was conducted in part at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory, and will be published in the July 2009 issue of Nature Reviews Microbiology, now available online.
› Verified 8 days ago
Dr. Joseph Stephen Brigance, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 201 Whitesport Drive, Huntsville, AL 35801 Phone: 256-881-5353 Fax: 256-881-0712 | |
Sundeep Alapati, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 927 Franklin St Se Ste 100, Huntsville, AL 35801 Phone: 256-536-9300 Fax: 256-535-9032 | |
Dr. Michael D Mcfadden, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1963 Memorial Parkway Sw, Suite 5, Huntsville, AL 35801 Phone: 256-536-9300 Fax: 256-535-9032 | |
Benjamin David Powell, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 201 Whitesport Dr Sw, Huntsville, AL 35801 Phone: 256-881-5353 Fax: 256-881-0712 | |
Dr. Neeta Kohli-dang, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 285 Chateau Dr, Huntsville, AL 35801 Phone: 256-882-0165 Fax: 256-882-7846 | |
Dr. Herman Mckinley Teachey, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1963 Memorial Parkway Sw, Suite 5, Huntsville, AL 35801 Phone: 256-536-9300 Fax: 256-535-9032 | |
Dr. Jason P Lockette, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 8 Ross St Nw, Huntsville, AL 35806 Phone: 256-366-0899 |